Top five unanswered questions in bacterial cell wall research by Sarah M. Batt, Katherine A. Abrahams, Gurdyal S. Besra

Get full text

DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid by Katherine A. Abrahams, Sarah M. Batt, Sudagar S. Gurcha, Natacha Veerapen, Ghader Bashiri, Gurdyal S. Besra

Get full text

Mycobacterial dihydrofolate reductase inhibitors identified using chemogenomic methods and in vitro validation. by Grace Mugumbate, Katherine A Abrahams, Jonathan A G Cox, George Papadatos, Gerard van Westen, Joël Lelièvre, Szymon T Calus, Nicholas J Loman, Lluis Ballell, David Barros, John P Overington, Gurdyal S Besra

Get full text

Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB. by Katherine A Abrahams, Jonathan A G Cox, Vickey L Spivey, Nicholas J Loman, Mark J Pallen, Chrystala Constantinidou, Raquel Fernández, Carlos Alemparte, Modesto J Remuiñán, David Barros, Lluis Ballell, Gurdyal S Besra

Get full text

Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target. by Sudagar S Gurcha, Veeraraghavan Usha, Jonathan A G Cox, Klaus Fütterer, Katherine A Abrahams, Apoorva Bhatt, Luke J Alderwick, Robert C Reynolds, Nicholas J Loman, VijayaShankar Nataraj, Carlos Alemparte, David Barros, Adrian J Lloyd, Lluis Ballell, Judith V Hobrath, Gurdyal S Besra

Get full text